Brock G. Bennion

648 total citations
9 papers, 464 citations indexed

About

Brock G. Bennion is a scholar working on Molecular Biology, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Brock G. Bennion has authored 9 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Epidemiology and 3 papers in Clinical Biochemistry. Recurrent topics in Brock G. Bennion's work include interferon and immune responses (3 papers), Sepsis Diagnosis and Treatment (3 papers) and Advanced Glycation End Products research (3 papers). Brock G. Bennion is often cited by papers focused on interferon and immune responses (3 papers), Sepsis Diagnosis and Treatment (3 papers) and Advanced Glycation End Products research (3 papers). Brock G. Bennion collaborates with scholars based in United States, Germany and Japan. Brock G. Bennion's co-authors include Derek J. Platt, Cathrine A. Miner, Jonathan J. Miner, Amber M. Smith, Teresa L. Ai, Paul R. Reynolds, Stephen W. Standage, Tomomi Sakai, Ricardo A. Irizarry-Caro and Vijay K. Gonugunta and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Virology and The FASEB Journal.

In The Last Decade

Brock G. Bennion

8 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brock G. Bennion United States 8 283 265 119 55 53 9 464
Rebeca Osca-Verdegal Spain 12 105 0.4× 231 0.9× 99 0.8× 86 1.6× 43 0.8× 18 490
Bhawna Tomar India 6 88 0.3× 117 0.4× 132 1.1× 67 1.2× 41 0.8× 10 364
Yanjun Zeng China 6 134 0.5× 115 0.4× 168 1.4× 56 1.0× 73 1.4× 8 419
Diba Emal Netherlands 6 126 0.4× 103 0.4× 31 0.3× 48 0.9× 34 0.6× 7 310
Sarah Kang United States 4 98 0.3× 195 0.7× 40 0.3× 53 1.0× 32 0.6× 5 309
P. Gollapudi United States 7 125 0.4× 51 0.2× 45 0.4× 61 1.1× 29 0.5× 9 369
Xiaoyan Gai China 11 88 0.3× 92 0.3× 68 0.6× 40 0.7× 130 2.5× 39 337
Caroline de Kerguenec France 6 107 0.4× 85 0.3× 116 1.0× 88 1.6× 11 0.2× 6 383
Sandro Lindig Germany 7 101 0.4× 102 0.4× 27 0.2× 110 2.0× 78 1.5× 8 359
Ashley van der Spek Netherlands 7 174 0.6× 103 0.4× 25 0.2× 120 2.2× 18 0.3× 10 431

Countries citing papers authored by Brock G. Bennion

Since Specialization
Citations

This map shows the geographic impact of Brock G. Bennion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brock G. Bennion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brock G. Bennion more than expected).

Fields of papers citing papers by Brock G. Bennion

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brock G. Bennion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brock G. Bennion. The network helps show where Brock G. Bennion may publish in the future.

Co-authorship network of co-authors of Brock G. Bennion

This figure shows the co-authorship network connecting the top 25 collaborators of Brock G. Bennion. A scholar is included among the top collaborators of Brock G. Bennion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brock G. Bennion. Brock G. Bennion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Bennion, Brock G., Erin K. Stenson, Danijel Djukovic, et al.. (2019). PPARαcontributes to protection against metabolic and inflammatory derangements associated with acute kidney injury in experimental sepsis. Physiological Reports. 7(10). e14078–e14078. 52 indexed citations
2.
Luksch, Hella, William A. Stinson, Derek J. Platt, et al.. (2019). STING-associated lung disease in mice relies on T cells but not type I interferon. Journal of Allergy and Clinical Immunology. 144(1). 254–266.e8. 84 indexed citations
3.
Bennion, Brock G., Harshad Ingle, Teresa L. Ai, et al.. (2018). A Human Gain-of-Function STING Mutation Causes Immunodeficiency and Gammaherpesvirus-Induced Pulmonary Fibrosis in Mice. Journal of Virology. 93(4). 47 indexed citations
4.
Irizarry-Caro, Ricardo A., Brock G. Bennion, Teresa L. Ai, et al.. (2017). STING-associated vasculopathy develops independently of IRF3 in mice. The Journal of Experimental Medicine. 214(11). 3279–3292. 142 indexed citations
5.
Standage, Stephen W., Martha A. Delaney, Brock G. Bennion, et al.. (2016). Nonhematopoietic Peroxisome Proliferator–Activated Receptor-α Protects Against Cardiac Injury and Enhances Survival in Experimental Polymicrobial Sepsis*. Critical Care Medicine. 44(8). e594–e603. 20 indexed citations
6.
Standage, Stephen W., Brock G. Bennion, Dolena Ledee, et al.. (2016). PPARα augments heart function and cardiac fatty acid oxidation in early experimental polymicrobial sepsis. American Journal of Physiology-Heart and Circulatory Physiology. 312(2). H239–H249. 52 indexed citations
7.
Bennion, Brock G., et al.. (2014). Conditionally induced RAGE expression by proximal airway epithelial cells in transgenic mice causes lung inflammation. Respiratory Research. 15(1). 133–133. 10 indexed citations
8.
Bennion, Brock G., et al.. (2012). RAGE signaling by alveolar macrophages influences tobacco smoke-induced inflammation. American Journal of Physiology-Lung Cellular and Molecular Physiology. 302(11). L1192–L1199. 57 indexed citations
9.
Bennion, Brock G., et al.. (2012). RAGE signaling influences tobacco smoke‐induced inflammation by pulmonary macrophages. The FASEB Journal. 26(S1).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026